New Event Launching in June Focusing on AI for Pharmaceuticals

April 26, 2021

By Bio-IT World Staff

April 26, 2021 | Bio-IT World and AI Trends are pleased to announce DECODE: AI for Pharmaceuticals, June 7-9, 2021, the first cross-functional conference to uncover AI’s true value for the pharmaceutical sector, while also focusing on data strategies, organizational change management, and implementation best practices.

Produced by Cambridge Innovation Institute, the conference company behind the Bio-IT World Conference & Expo and AI World, DECODE: AI for Pharmaceuticals plans to fill a gap in the conference landscape for an event that combines AI technologies with the needs and business goals of pharmaceutical companies. Uniting innovation, data, digital and IT leaders from across the entire pharmaceutical product pipeline, this use-case-led program goes beyond the hype of AI to identify where the true value lies, what business outcomes are within reach, and how to navigate the technology implementation journey.

“With times of crises so often spurring innovation, it is no secret that the application of AI has recently accelerated, playing a critical role in the race to discover and bring to market effective vaccines in the fight against COVID-19,” says Dominie Roberts, Senior Conference Director, Cambridge Innovation Institute. “In spite of these recent advances, pharmaceutical organizations still have a long way to go in order to achieve true, scalable AI for maximum gains. Outdated innovation strategies and data models must be redefined, and now is the time for the industry to come together to share insights and learnings, to ensure it can continue to build on the recent AI momentum,”

The 3-day program will include focused content on:

  • Day 1: structuring your data for AI
  • Day 2: change management and strategies for uncovering AI value
  • Day 3: cross-functional AI use cases & implementation best practices

The DECODE event will run in the same week as the AI Innovation Circle, an exclusive partnering program which unites investors, founders & strategic industry partners advancing AI for Healthcare & Life Science.